{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "68001-328",
      "generic_name": "Triamterene and Hydrochlorothiazide",
      "labeler_name": "BluePoint Laboratories",
      "brand_name": "Triamterene and Hydrochlorothiazide",
      "active_ingredients": [
        {
          "name": "TRIAMTERENE",
          "strength": "75 mg/1"
        },
        {
          "name": "HYDROCHLOROTHIAZIDE",
          "strength": "50 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "68001-328-00",
          "description": "100 TABLET in 1 BOTTLE (68001-328-00)",
          "marketing_start_date": "20170430",
          "sample": false
        },
        {
          "package_ndc": "68001-328-03",
          "description": "500 TABLET in 1 BOTTLE (68001-328-03)",
          "marketing_start_date": "20170430",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "BluePoint Laboratories"
        ],
        "rxcui": [
          "310812",
          "310818"
        ],
        "spl_set_id": [
          "4f44fb73-7f61-4623-ae89-61abd8e945ab"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0368001327008",
          "0368001328005"
        ],
        "nui": [
          "N0000175359",
          "N0000175419",
          "M0471776",
          "N0000008859",
          "N0000175418"
        ],
        "pharm_class_pe": [
          "Increased Diuresis [PE]",
          "Decreased Renal K+ Excretion [PE]"
        ],
        "pharm_class_epc": [
          "Thiazide Diuretic [EPC]",
          "Potassium-sparing Diuretic [EPC]"
        ],
        "pharm_class_cs": [
          "Thiazides [CS]"
        ],
        "unii": [
          "0J48LPH2TH",
          "WS821Z52LQ"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "40090f26-7b8d-b3e7-e063-6394a90a7cb4",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20170430",
      "product_id": "68001-328_40090f26-7b8d-b3e7-e063-6394a90a7cb4",
      "application_number": "ANDA071251",
      "brand_name_base": "Triamterene and Hydrochlorothiazide",
      "pharm_class": [
        "Decreased Renal K+ Excretion [PE]",
        "Increased Diuresis [PE]",
        "Increased Diuresis [PE]",
        "Potassium-sparing Diuretic [EPC]",
        "Thiazide Diuretic [EPC]",
        "Thiazides [CS]"
      ]
    }
  ]
}